Avner Schlessinger

2K posts

Avner Schlessinger banner
Avner Schlessinger

Avner Schlessinger

@SchlessingerLab

Computational biologist. Professor. Co-Director of Disease Mechanisms and Therapeutics Training Area @IcahnMountSinai. Opinions are mine. #DrugDesign #AI

New York, NY Присоединился Eylül 2017
2.9K Подписки2.7K Подписчики
Avner Schlessinger
Avner Schlessinger@SchlessingerLab·
My interview with Technology Networks on rethinking target-based drug discovery. We discuss why target-first approaches often fail and how AI and structure-guided methods can better link targets to therapeutic impact. tinyurl.com/5evzw7h8 #DrugDiscovery #AIDrugDiscovery 🔗
English
0
1
2
661
Avner Schlessinger ретвитнул
Yuval Itan
Yuval Itan@ItanLab·
V2P (variant-to-phenotype) is live: nature.com/articles/s4146… To our knowledge, first genomewide SNVs+indels (coding+noncoding incl. intergenic) model jointly predicting pathogenicity + disease domain (23 HPO groups; e.g. cardiac/immune/metabolic). @david_stientist @SchlessingerLab
Yuval Itan tweet media
English
1
29
86
9.3K
Avner Schlessinger ретвитнул
Grad School at Icahn Mount Sinai
Grad School at Icahn Mount Sinai@GradSchoolSinai·
Do you know what a PhD in Biomedical Sciences or Neuroscience can do for your career? Join us tomorrow from 4-5pm ET for a special information session featuring alumni from the Graduate School of Biomedical Sciences: mshs.co/4eWFLxw
Grad School at Icahn Mount Sinai tweet media
English
0
3
4
471
Avner Schlessinger ретвитнул
Daniel Wacker
Daniel Wacker@WackerLab·
Our latest work: As it turns out different positive allosteric modulators bind to different sites at the mu opioid receptor. Find out more in our @biorxivpreprint. biorxiv.org/content/10.110…
Daniel Wacker tweet media
English
0
7
13
1.7K
Avner Schlessinger ретвитнул
C&EN (Chemical & Engineering News)
C&EN (Chemical & Engineering News)@cenmag·
Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. Despite AI’s use at each step, the billion-dollar question is whether it can bring a larger number of novel drugs to market. cen.acs.org/physical-chemi…
English
0
1
3
1.1K
Igor Ulitsky
Igor Ulitsky@IgorUlitsky·
Busy times ahead. I apologize in advance for potentially taking longer to respond to e-mails for a few years...
Weizmann Institute@WeizmannScience

Congratulations to Prof. @IgorUlitsky of the Department of Immunology and Regenerative Biology, upon being appointed as the new Dean of the Faculty of Biology. Prof. Ulitsky will assume his role on December 1, 2025

English
28
1
168
6.7K
Avner Schlessinger ретвитнул
Aya Osman, PhD
Aya Osman, PhD@AyaOsman·
Official announcement: this September 1, the Osman laboratory will be opening its doors in the biological sciences department at SUNY, Albany! Anyone interested in joining the lab, please contact me. aosman@albany.edu Lab website coming soon! @ualbany
Aya Osman, PhD tweet mediaAya Osman, PhD tweet media
English
39
53
417
35.9K
Avner Schlessinger ретвитнул
Yuval Itan
Yuval Itan@ItanLab·
A postdoc position is open in my lab to develop AI/ML models for predicting functional effects of genetic variants and to lead large-scale PheWAS in major biobanks. Strong programming skills, a solid publication record, and a background in human genetics are required.
English
1
13
23
2.9K
Avner Schlessinger ретвитнул
Jay Bhattacharya, MD, PhD
Jay Bhattacharya, MD, PhD@NIHDirector_Jay·
Today, @NIH announced a new policy to cap how much publishers can charge NIH-supported scientists to make their work publicly accessible. This reflects our broader effort to restore public trust in public health by creating an open, honest, and transparent research atmosphere. Read more ➡️ bit.ly/4nCdIbl
Jay Bhattacharya, MD, PhD tweet media
English
105
461
2.6K
190K

Открыть

@david_stientist @ItanLab @biorxivpreprint @IgorUlitsky @barak_hirshberg @AmerChemSociety @ACSCOMP @OpenEyeSoftware